Announcement

Collapse
No announcement yet.

Int J Infect Dis Use of Anakinra in Severe COVID-19: A Case Report

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Int J Infect Dis Use of Anakinra in Severe COVID-19: A Case Report


    Int J Infect Dis


    . 2020 May 10;S1201-9712(20)30333-7.
    doi: 10.1016/j.ijid.2020.05.026. Online ahead of print.
    Use of Anakinra in Severe COVID-19: A Case Report


    Giovanni Filocamo 1 , Davide Mangioni 2 , Paola Tagliabue 3 , Stefano Aliberti 4 , Giorgio Costantino 5 , Francesca Minoia 6 , Alessandra Bandera 7



    Affiliations

    Abstract

    Coronavirus Disease 19 is a global healthcare emergency with high lethality rate. Relevant inflammatory cytokine storm is associated with severity of disease and IL1 inhibition is a cornerstone treatment for hyperinflammatory diseases. We present here the case of a patient with critical COVID-19 successfully treated with IL-1 receptor antagonist (anakinra).

    Keywords: Anakinra; Biologic; COVID-19; IL-1; Treatment.



    Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Working...
X